Aims We sought to compare diastolic parameters in patients having type 1 diabetes mellitus (DM) and healthy controls using both pulse-wave (PW) Doppler and relatively novel tissue-Doppler imaging (TDI) to evaluate the possible effect of diabetes on left ventricular dysfunction. Methods and results One hundred and thirty-two patients were evaluated (81 type 1 diabetic patients and 51 healthy volunteers). The detailed M-mode, two-dimensional, colour Doppler; PW Doppler; and TDI analyses were performed on resting subjects in a regular setting. Posterior wall thickness, left atrial indexed diameter, and A velocity were significantly higher in the diabetics when compared with control group (P ¼ 0.019, ,0.001, 0.033, respectively). Rest of the M-mode and PW Doppler parameters of diabetics were comparable with those of control subjects (P . 0.05 for all). However, both septal E 0 and lateral E 0 velocities were significantly lower in diabetics than in the control subjects on TDI echocardiographic examination (P , 0.001 and 0.011, respectively). In addition, E 0 /septal E 0 and E/lateral E 0 ratios were significantly higher in the diabetic group (P , 0.001 and 0.008, respectively). Conclusion TDI is a more accurate and powerful method than PW or M-mode in determination of early cardiac involvement related to type 1 DM even in the subclinical phase as well as hereditary cardiomyopathies.
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Introduction
It has been well documented that the presence of diabetes mellitus (DM) was closely linked to cardiovascular disease. DM surely portends cardiac morbidity and mortality [1] [2] [3] even in the absence of risk factors including ischaemic, valvular, or hypertensive heart disease. 4, 5 Primary 'diabetic cardiomyopathy' is suggested to be responsible for adverse cardiac events. 6, 7 It has been defined in guidelines as a risk factor in development of heart failure. 8 Diastolic dysfunction (DD) is currently determined as a separate clinical entity. 9, 10 It is important to recognize DD because of increased morbidity and mortality. 11, 12 Although cardiac catheterization has been accepted as a 'gold standard' for assessment of DD, it is invasive, clinically unpractical, and expensive diagnostic method to perform. 13, 14 Thus, it is mainly reserved for research investigations because of limited feasibility. Pulsed-wave (PW) Doppler echocardiography has been subsequently validated for the diagnosis of DD and has emerged because it is widely available, less expensive, and non-invasive imaging modality. 15 Despite its pivotal, the initial stage of subclinical cardiovascular disease may be concealed due to various compensatory mechanisms. 16 Tissue-Doppler imaging (TDI) provides more accurate data in detection of DD than PW Doppler. 17 Furthermore, TDI may be used in conjunction with pulsed Doppler to estimate left ventricular filling pressures. 18 Thus, TDI has a frank complementary role in the assessment of DD. Therefore, TDI has been reported to be a routine application in clinical practice.
Few studies have been examined DD using TDI in type 1 diabetic patients. [19] [20] [21] [22] Nevertheless, exact effect of diabetes-related factors (glycemic control, duration of diabetes, occurrence of complication) on diastolic function is still controversial and has been poorly settled. 20, 23 We sought to compare diastolic parameters of both PW Doppler and relatively novel TDI in patients having type 1 DM and healthy controls to evaluate the impact of possible diabetes on left ventricular dysfunction.
Methods

Patient selection
One hundred and thirty-two patients were enrolled to the present study. The diabetic group included 81 type 1 DM patients who were hospitalized in the endocrinology department. The control group included 51 healthy volunteers who admitted to our hospital for check-up and underwent echocardiographic evaluation. Both groups were enrolled and examined in the same period. Patients older than 40 years, having arterial hypertension (.130/80 mmHg in the sitting posture and/or on antihypertensive treatment), left ventricular hypertrophy, congenital heart disease, ischaemic heart disease [evaluated by electrocardiogram (ECG), treadmill test, and echocardiography], any bundle branch block, cardiac dysrhythmias, valvular heart disease, left ventricle systolic dysfunction, renal disease, thyroid dysfunction, pulmonary hypertension, pregnancy, systemic diseases, and patients on any medication other than insulin were excluded. The same exclusion criteria were used for the normal subjects.
All subjects gave informed consent for their participation. The study protocol was performed with approval of local ethics committee and confirmed to the Declaration of Helsinki.
Baseline characteristics and laboratory measurements
The baseline measurements of weight and height were recorded, and body mass index (BMI) was calculated for each subjects. BMI was defined as the ratio of individual's body weight to the square of the height. Before the echocardiographic examination, ECG was taken in supine position. Maximal treadmill test in accordance with the modified Bruce protocol was performed to participants to exclude ischaemic heart disease if required. 24 Lipid profile including total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL) were measured by colorimetric enzymatic method (Aerost device, Abbott Diagnostics, USA) after 10-12 h of overnight fasting. In addition, glycemic control of diabetic group was assessed using glycated haemoglobin (HbA1c), which was considered to be indicator of glycemic control of last 3 month. HbA1c was measured in the blood sample by immunoturbidimetric method (C8000 device, Abbott Company, USA).
Echocardiography
All measurements were taken by two experienced cardiologists who were unaware about study protocol. The detailed M-mode, twodimensional, colour Doppler; PW Doppler; and TDI analyses were performed on resting subjects in a regular setting by a Vivid 7 (General Electric, USA) imaging system with a 2.5 MHz transducer.
All parameters were taken on the basis of the American Society of Echocardiography standards. 25 LV end-diastolic and end-systolic diameters, end-diastolic septal and posterior wall thicknesses, and end-systolic left atrium diameter were derived from M-mode evaluation. LV mass was calculated by the modified formula of Devereux et al. 26 LV end-diastolic and end-systolic diameters, left atrium diameter, and LV mass were evaluated on the basis of body surface area. Modified Simpson's method was used to determine LV ejection fraction. 27 Mitral inflow velocities were evaluated by PW Doppler from apical four-chamber view with the sample volume positioned at the tip of the mitral leaflets and at an angle as parallel to mitral flow as possible. The following parameters were measured: peak early filling velocity (E), peak late atrial filling velocity (A), E/A ratio, deceleration time of E velocity (DT), and isovolumic relaxation time (IVRT).
Spectral PW Doppler signal filters were used with the lowest wall filter settings and the minimum optimal gain at a Nyquist limit of 15 and 20 cm/s to eliminate signals produced by transmitral flow. In the apical four-chamber view, Doppler sample volume was placed at septal and lateral mitral annulus. The angle between the Doppler beam and the longitudinal motion of mitral annulus was minimized, as well. Thus, early peak velocities of septal and lateral mitral annulus (septal E 0 , lateral E 0 ) were obtained, as described in detail previously. 27 E/septal E 0 and E/lateral E 0 ratios, which are used to estimate LV filling pressure, were also calculated. 18 All Doppler parameters were recorded at a horizontal speed of 100 mm/s. The average values obtained at least three consecutive cardiac cycles were taken in to consideration in statistical analysis.
Statistical analysis
Statistical analysis was performed by Statistical Package for Social Sciences (SPSS) 11.5 software (SPSS Inc., Chicago, IL, USA). The distributions of continuous variables were determined using ShapiroWilk test. Data were shown as mean + standard deviation for continuous variables. Categorical variables were presented as percentages. Continuous variables were compared using Student's t-or Mann-Whitney U tests, where appropriate. Degree of association between continuous variables was calculated by Pearson's correlation coefficient. Multiple linear regression analysis were applied to determine whether the statistically significant difference between type 1 DM and control groups regarding TDI and filling pressure parameters to be continued or not adjusted for age, sex, and BMI. In addition, the association between TDI and filling pressure parameters with duration of symptom, existence of complication were evaluated by multiple regression analysis adjusted for age, sex, and BMI in type 1 DM group. Coefficient of regression and 95% CI for all independent factors were calculated. A P-value of ,0.05 was considered statistically significant.
Results
Clinical characteristics
Demographic, clinical, and laboratory data were presented in Table 1 . Heart rate in diabetic group was higher when compared with normal group (83.7 + 13.7 vs. 75.1 + 10.0, P , 0.001, respectively). However, remaining parameters were similar in both groups (P . 0.05 for all).
Echocardiography
Data derived from echocardiography were presented in Table 2 . Posterior wall thickness, left atrial indexed diameter, and A velocity were significantly higher in the diabetics when compared with control group (P ¼ 0.019, 0.001, 0.033, respectively). The M-mode and PW Doppler parameters of diabetics were comparable with those of control subjects (P . 0.05 for all). However, on TDI echocardiographic examination, both septal E 0 and lateral E 0 velocities were found significantly lower in diabetics than in the control subjects (P , 0.001 and 0.011, respectively). E/septal É and E/lateral É ratios were significantly higher in the diabetic group (P , 0.001 and 0.008, respectively).
On correlation analysis having type 1 DM was found a solely independent correlate after adjusting for BMI, age, and gender in terms of TDI and filling pressure parameters ( Table 3) . In the second model, we tested respective impact of DM duration, HbA 1 c, and complication occurrence on TDI and filling pressure parameters among diabetic group. Although DM duration and complication occurrence were correlated with these parameters, such a correlation regarding to HbA 1 c was not disclosed ( Table 4) . In the final model, correlation of complication occurrence and DM duration with TDI and filling pressure parameters at the septal annulus still remained significant when adjusted for BMI, age, and gender. However, significant correlation was found only between lateral E 0 and complication occurrence after adjusting for BMI, age, and gender ( Table 5) .
Discussion
The main findings of the present study suggest that type 1 DM subjects are characterized with impaired diastolic and LV filling pressure parameters, even in the absence of accompanying cardiac diseases, and type 1 DM is an independent correlate for these impairments. Furthermore, a strong correlation was found between impairment of diastolic parameters and DM duration and diabetic complication occurrence. These results support the concept of a subclinical specific diabetic cardiomyopathy, which develops before obvious systolic dysfunction in patients with type 1 DM. Existence of a distinct diabetic cardiomyopathy has been claimed to cause DD formerly. 28, 29 In addition, DD has been shown to precede systolic dysfunction in diabetics, even before the presence of pathological findings on clinical examination. 30 Thus, impairment of diastolic parameters may be used as an early preclinical manifestation of diabetic cardiomyopathy. 17 Moreover, diabetics without cardiac disease have already been reported to have a putative DD and our data in diabetic population by TDI were in the same line with the previous studies. 23, [31] [32] [33] The diastolic properties measured in young type 1 DM patients is reported to deteriorate more rapidly and well correspond with the measures of older ages. 34 In accordance with these data reflecting early diastolic impairment, patients in our study had decreased annular velocities with increased LV filling pressures. Finally, larger indexed left atrium diameters in the diabetic group supported diastolic impairment.
In contrast with our results, there are several studies not supporting diastolic alterations among diabetics as well. 19, 20 They explained the discrepancy on the basis of lack of uniformity in patient inclusion and exclusion criteria between studies in terms of glycemic control, DM duration, DM complication occurrence, gender, BMI, and age. The use of different echocardiographic techniques that are not equally sensitive in detecting diastolic impairment may also, in part, account for these contradictory results. For example, the accuracy of PW Doppler is limited in the setting of pseudonormal pattern, which can be unmasked by preload reducing conditions such as Valsalva manoeuvre. It appears that TDI is useful to overcome this outstanding problem. 17 Furthermore, addition of TDI to PW Doppler has been reported to improve the echocardiographic diagnosis of diastolic impairment in diabetic population. 17 In agreement with these data, TDI and filling parameters were significantly different between the two groups in our study, while no significant difference was found between PW Doppler parameters in both groups. This means that DD can be detected by TDI at an early stage while PW parameters are normal in patients with type 1 DM. Thus, determination of diastolic impairment may be overlooked when it is evaluated solely based on PW Doppler.
In addition, there is not homogenity between the studies that used TDI to evaluate diastolic parameters. 20, 23 Septal annular velocity was used as a diastolic parameter in three of them whereas lateral annular velocity was used in one study. 23 The sum of the lateral, septal, anterior, and posterior annular velocities were used in a recent study reported by Peterson et al. 20 However, they previously reported that lateral and septal annular velocities had not same value determining DD and these velocities could be used interchangeably. 35, 36 It has been suggested to use lateral annular velocity in the setting of normal systolic function preferentially. 37, 38 In present study, we evaluated and compared both annular velocities in the guidance of these data. Septal annular velocity was correlated with both DM duration and DM complication occurrence whereas lateral annular velocity was correlated with only DM complication occurrence in the present study. This seems to support hypothesis that septal and lateral velocities are affected by different factors and not the same indices.
Impaired diastolic parameters were independently related to diabetes duration as confirmed by previous studies. 19, 39, 40 Our data concerning the correlation between DM duration and diastolic impairment emphasize the progressive nature of the process. In addition to this correlation, diabetes duration was also found to be a predictor of the impairment of aortic distensibility in diabetics. 41 This finding really seems to support that the effect of diabetes on diastolic parameters is progressive and occurs in the course of time. Of interest, diabetes duration in our study was highly relevant with the suggestion that DD appeared to take place 8 years after the onset of diabetes. 31 It has been stressed that there was not a constant correlation between diastolic parameters and diabetic complications. 42 Some studies documented diastolic impairment in the setting of complications; nevertheless, some studies were not able to show such correlation. 43, 44 We showed significant correlation between complication occurrence and impaired diastolic parameters. But it is hard to compare the studies as similar echocardiographic techniques were not used for the evaluation of diastolic parameters. Potential effect of hypertension on the appearance of diastolic impairment among complicated diabetic patients was postulated to be the explanatory reason. 45 This, confounding impact of HT seemed to be unlikely in our study, as all diabetic subjects were definitely normotensive.
We found no correlation between glycemic control and diastolic function, some reasons exist for this finding. First, Hiramatsu et al. 46 found that the correlation of glycemic control and diastolic parameters was more evident in the subgroup of uncomplicated diabetics. We found correlation between glycemic control and diastolic parameters because the present study included complicated diabetic patients. Second, this issue may be partly explained by the fact that a single HbA 1 c may not reflect the overall control of diabetes; in addition, it may cause insufficient and deceptive information about long-term glycemic control. So, the mean HbA 1 c value averaged over several years instead of a single instantaneous value may provides more accurate information about glycemic control.
Conclusion
TDI may be beneficial in the determination of early cardiac involvement of hereditary cardiomyopathies even in the subclinical phase. 47 Early intervention of the subclinical disease has shown to produce favourable outcomes in favour of the patients. TDI may permit early identification of dilated cardiomyopathy and, consequently progression of the disease can be controlled. The presence of subclinical cardiovascular disease in DM appears to be associated with significantly increased adjusted relative risk of death, relative risk of incident coronary heart disease, and myocardial infarction. Despite the speculation in diabetes, there is no adequate data. Thus, as an important determinant of clinical cardiovascular disease among diabetic population, detection of subclinical cardiac involvement in diabetics may provide an approach for identifying high-risk patients who are likely to benefit from an earlier intervention. There is a need for further echocardiographic studies advanced comments. Unfortunately, there is no consensus to apply echocardiography for diabetics in routine clinical practice.
Study limitations
We did not perform coronary angiography to exclude coronary artery disease on ethical grounds. So, we carefully excluded the patients with obvious ischaemic symptoms, ECG changes, cardiac stress test, and echoardiographic findings. Nevertheless, there may be asymptomatic patients whose cardiac stress test also evaluated negative for ischaemia in the present study. However, we believe that these limitations do not invalidate the main results of the study. Evaluation of glycemic control on the basis of a single HbA1c measurement was another limitation. In addition, HbA1c was not measured in control group, so the impact of glysemic control on diastolic function was not evaluated more clearly.
Diastolic properties of type 1 diabetics can be easily and practically assessed by TDI. In addition, asymptomatic type 1 DM patients may have significant changes in diastolic parameters, which are thought to herald the risk of developing cardiomyopathy. DM duration and complication occurrence seem to affect this process. These results may contribute to better understanding of mechanisms, resulting in adverse cardiac events in type 1 DM, enable to tailor potential treatment, and help to achieve optimal outcomes. Nevertheless, we need to be further more homogenous and larger studies.
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